Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma

Running, not enrolling

Conditions studied: Brain Neoplasm, Low Grade Glioma, Seizure Disorder

In brief

This study investigates how seizures can vary over time with changes in low grade gliomas and its treatments. This study may help doctors find symptoms or triggers of seizures earlier than normal, and ultimately earlier care or treatment for seizures.

Key facts

Study ID

NCT04553757

Run by

M.D. Anderson Cancer Center

People needed

100

Starts

2020-07-08

Expected to finish

2027-12-30

Last updated by the study team

2026-04-23

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients
• Primary brain tumors (separated by World Health Organization [WHO] grade I-IV)
• History of seizures secondary to brain tumor
• On tumor directed treatment
• Magnetic resonance imaging (MRI) within 2 weeks of clinic visit where seizure assessment takes place

You may not qualify if…

• Patients without seizures
• Patients with intracranial lesions other than primary brain tumor
• Patients not undergoing tumor directed treatment
• Absence of recent (within 2 weeks) MRI

Where it is running

• M D Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.